- Home
- CLBT vs PTGX Comparison
CLBT vs PTGX Comparison
Compare CLBT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBT
- PTGX
- Stock Information
- Founded
- CLBT 1999
- PTGX 2006
- Country
- CLBT Israel
- PTGX United States
- Employees
- CLBT N/A
- PTGX N/A
- Industry
- CLBT Computer Software: Prepackaged Software
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- CLBT Technology
- PTGX Health Care
- Exchange
- CLBT Nasdaq
- PTGX Nasdaq
- Market Cap
- CLBT 4.2B
- PTGX 4.0B
- IPO Year
- CLBT N/A
- PTGX 2016
- Fundamental
- Price
- CLBT $18.80
- PTGX $75.92
- Analyst Decision
- CLBT Strong Buy
- PTGX Strong Buy
- Analyst Count
- CLBT 5
- PTGX 8
- Target Price
- CLBT $22.60
- PTGX $74.13
- AVG Volume (30 Days)
- CLBT 1.2M
- PTGX 1.6M
- Earning Date
- CLBT 11-12-2025
- PTGX 10-31-2025
- Dividend Yield
- CLBT N/A
- PTGX N/A
- EPS Growth
- CLBT N/A
- PTGX N/A
- EPS
- CLBT N/A
- PTGX 0.80
- Revenue
- CLBT $436,732,000.00
- PTGX $209,180,000.00
- Revenue This Year
- CLBT $19.44
- PTGX N/A
- Revenue Next Year
- CLBT $16.78
- PTGX $142.86
- P/E Ratio
- CLBT N/A
- PTGX $93.05
- Revenue Growth
- CLBT 20.48
- PTGX N/A
- 52 Week Low
- CLBT $13.10
- PTGX $33.31
- 52 Week High
- CLBT $26.30
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- CLBT 56.19
- PTGX 59.40
- Support Level
- CLBT $17.66
- PTGX $73.08
- Resistance Level
- CLBT $18.52
- PTGX $77.66
- Average True Range (ATR)
- CLBT 0.60
- PTGX 4.58
- MACD
- CLBT -0.12
- PTGX -0.42
- Stochastic Oscillator
- CLBT 57.58
- PTGX 39.72
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.